Jasper Therapeutics Inc

JSPRNASDAQ · USD
0.62USD0.00 (-2.58%)
112

Jasper Therapeutics Inc (JSPR) Options Open Interest

JSPR options open interest is 7,117 contracts. The 2-week average daily volume is 495 contracts across the chain.

Read more

Monitoring JSPR open interest helps you see where real money is positioned on Jasper Therapeutics Inc's options and which strikes are attracting the most commitment from traders. Jasper Therapeutics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor JSPR options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising JSPR options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Jasper Therapeutics Inc to settle.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy.

It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where JSPR open interest is concentrated. Our scanner maps Jasper Therapeutics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Jasper Therapeutics Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16

Loading option chain…

Calls
Puts

As of September 18, 2026

Follow the money

Track JSPR open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial